| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 34388 |
| 1 | PREDNISONE | 27556 |
| 2 | METHOTREXATE SODIUM | 20839 |
| 3 | INFLIXIMAB | 19849 |
| 4 | METHOTREXATE | 18892 |
| 5 | RITUXIMAB | 16727 |
| 6 | ETANERCEPT | 16511 |
| 7 | ACETAMINOPHEN | 15980 |
| 8 | ERGOCALCIFEROL | 12105 |
| 9 | TOCILIZUMAB | 11379 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 6650 | 0.5263 |
| 1 | RITUXIMAB-ABBS | 1171 | 0.5138 |
| 2 | IVOSIDENIB | 562 | 0.4930 |
| 3 | OMADACYCLINE | 163 | 0.4895 |
| 4 | RITUXIMAB-PVVR | 348 | 0.4531 |
| 5 | ISAVUCONAZONIUM SULFATE | 661 | 0.3357 |
| 6 | PURIXAN | 186 | 0.3196 |
| 7 | BECAPLERMIN | 672 | 0.3191 |
| 8 | DEFIBROTIDE SODIUM | 684 | 0.3161 |
| 9 | ANAKINRA | 3281 | 0.2928 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 59282 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 43168 |
| 2 | RANK Ligand Inhibitor [EPC] | 34388 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32304 |
| 4 | Kinase Inhibitor [EPC] | 21461 |
| 5 | Atypical Antipsychotic [EPC] | 21320 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 20046 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 19488 |
| 8 | Benzodiazepine [EPC] | 19200 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 18852 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthrax Protective Antigen-directed Antibody [EPC] | 1 | 0.5000 |
| 1 | Melanocortin 4 Receptor Agonist [EPC] | 10 | 0.4167 |
| 2 | Antileishmanial [EPC] | 73 | 0.3244 |
| 3 | Human Platelet-derived Growth Factor [EPC] | 672 | 0.3191 |
| 4 | Lead Chelator [EPC] | 18 | 0.3158 |
| 5 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 127 | 0.2947 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 3281 | 0.2928 |
| 7 | Interferon gamma Blocker [EPC] | 12 | 0.2308 |
| 8 | RANK Ligand Inhibitor [EPC] | 34388 | 0.2113 |
| 9 | Lipoglycopeptide Antibacterial [EPC] | 154 | 0.2104 |